New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Eli Lilly (NYSE: LLY) has been experiencing fantastic growth due to the success of its GLP-1 drugs, Mounjaro (approved for ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.

Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting Tuesday that the drug led ...

Weight loss drugs such as Ozempic, Mounjaro and Zepbound can deliver good results, but new research suggests the success may be short-lived. A new study suggests that that once people stop taking ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

Jerry Clark says he's transformed his tastebuds, changed his portion sizes, and made fitness a non-negotiable.

Oprah Winfrey discusses GLP-1 weight-loss medications and obesity as a disease, challenging long-held misconceptions about willpower and food addiction.

Analysis of a large unsubsidized digital weight-loss service reveals that consistent treatment adherence and active engagement, not access alone, are the key factors separating modest results from ...

Midland Health’s Weigh to Success returns in 2026 with lifestyle medicine, CBT, medications and bariatric surgery to help ...

Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...

DAKOTA DUNES, S.D. (KTIV) - A new year can mean a new “you” as many Americans look to weight loss as a New Year’s resolution. The team at CNOS in Dakota Dunes, South Dakota, has a comprehensive ...